Who backs Ambros Therapeutics?
9 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Arkin Capital | Family office |
| Adage Capital Management | Hedge fund |
| Balyasny Asset Management | Hedge fund |
| Abiogen Pharma | — |
| Enavate Sciences | — |
| Janus Henderson Investors | — |
| LifeSci Venture Partners | — |
| Transhuman Capital | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Ambros Therapeutics investors
9 investors are on record for Ambros Therapeutics, including RA Capital Management, Arkin Capital, Adage Capital Management and Balyasny Asset Management. The Series A in Dec 2025 drew 8 investors.
Free account
More of Ambros Therapeutics with a free account
- ·Watch Ambros Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 9 firms already write checks for companies like Ambros Therapeutics in biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View